BioLineRx Ltd • BLRX

Capital at risk.

About BioLineRx Ltd
Ticker
info
BLRX
Trading on
info
NASDAQ
ISIN
info
US09071M3043
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
-
Headquarters
info
Modi’in Technology Park, Hevel Modi'in, undefined, Israel, 7177871
Employees
info
79
Website
info
biolinerx.com
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Metrics
BasicAdvanced
Market cap
info
$12.1M
P/E ratio
info
-
EPS
info
-$12.00
Dividend Yield
info
0.00%
Beta
info
0.93
Forward P/E ratio
info
0
EBIDTA
info
$-25.5M
Ex dividend date
info
-
Price & volume
Market cap
info
$12.1M
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0.2
Trailing P/E
info
0
Price to sales
info
0.55
Price to book
info
1.42
Earnings
EPS
info
-$12.00
EPS estimate (current quarter)
info
-$0.11
EPS estimate (next quarter)
info
-$0.11
EBITDA
info
$-25.5M
Revenues (TTM)
info
$22M
Revenues per share (TTM)
info
$11.40
Technicals
Beta
info
0.93
52-week High
info
$56.00
52-week Low
info
$2.88
50-day moving average
info
$3.89
200-day moving average
info
$17.18
Short ratio
info
1.72
Short %
info
7.00%
Management effectiveness
ROE (TTM)
info
184.09%
ROA (TTM)
info
32.96%
Profit margin
info
90.57%
Gross profit margin
info
$15.1M
Operating margin
info
108.98%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
3.6M
Float
info
1.14B
Insiders %
info
4.68%
Institutions %
info
1.41%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$160.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.15
-$0.16
6.25%
Q4 • 23Beat
-$0.01
-$0.29
96.55%
Q1 • 24Beat
$0.01
-$0.14
104.36%
Q2 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$5.4M
$0.5M
8.97%
Q2 • 24
$4.9M
$-5.8M
117.78%
Q3 • 24
8.34%
1,302.89%
1,412.40%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$64.6M
$50.6M
78.36%
Q2 • 24
$52.7M
$44.2M
83.87%
Q3 • 24
18.35%
12.60%
7.04%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-11.3M
$-8.6M
$23.9M
$-11.4M
Q2 • 24
$-9.8M
$10.2M
$-1.2M
$-9.8M
Q3 • 24
13.28%
217.70%
105.10%
13.48%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a BioLineRx Ltd share?
Collapse

BioLineRx Ltd shares are currently traded for undefined per share.

How many shares does BioLineRx Ltd have?
Collapse

BioLineRx Ltd currently has 3.6M shares.

Does BioLineRx Ltd pay dividends?
Collapse

No, BioLineRx Ltd doesn't pay dividends.

What is BioLineRx Ltd 52 week high?
Collapse

BioLineRx Ltd 52 week high is $56.00.

What is BioLineRx Ltd 52 week low?
Collapse

BioLineRx Ltd 52 week low is $2.88.

What is the 200-day moving average of BioLineRx Ltd?
Collapse

BioLineRx Ltd 200-day moving average is $17.18.

Who is BioLineRx Ltd CEO?
Collapse

The CEO of BioLineRx Ltd is -.

How many employees BioLineRx Ltd has?
Collapse

BioLineRx Ltd has 79 employees.

What is the market cap of BioLineRx Ltd?
Collapse

The market cap of BioLineRx Ltd is $12.1M.

What is the P/E of BioLineRx Ltd?
Collapse

The current P/E of BioLineRx Ltd is null.

What is the EPS of BioLineRx Ltd?
Collapse

The EPS of BioLineRx Ltd is -$12.00.

What is the PEG Ratio of BioLineRx Ltd?
Collapse

The PEG Ratio of BioLineRx Ltd is 0.2.

What do analysts say about BioLineRx Ltd?
Collapse

According to the analysts BioLineRx Ltd is considered a buy.